Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Glucose Metabolism Disorders » Hyperglycemia » Glucose Intolerance
Description
A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION. MeSH
Hierarchy View
Phase 4 Indicated Drugs (26)
Phase 3 Indicated Drugs (8)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (50)
Organization Involved with Phase 4 Indications (54)
Hospital General de México Dr. Eduardo Liceaga
Hospital Regional Alta Especialidad Bajio
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization Involved with Phase 3 Indications (40)
Canadian Institutes of Health Research (CIHR)
Fondazione per la ricerca sulla Fibrosi Cistica
Heart and Stroke Foundation of Canada
Icahn School of Medicine at Mount Sinai
National Cheng Kung University
National Medical Centre Siglo XXI Mexican Institute for Social Security
Organization Involved with Phase 2 Indications (46)
Juvenile Diabetes Research Foundation
National Center for Complementary and Integrative Health (NCCIH)
National Center for Research Resources (NCRR)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Allergy and Infectious Diseases (NIAID)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (96)
Agricultural Producers' Cooperative Corporation Shinpo-en
All India Institute of Medical Sciences
Centre National d'Etudes Spatiales
Chinese Academy of Medical Sciences
European Foundation for the Study of Diabetes
Federal University of Health Science of Porto Alegre
Federal University of Rio Grande do Sul
Federal University of Sao Paulo
Hellenic National Diabetes Center
HSC Research & Development Division, Public Health Agency, Northern Ireland
Illinois Institute of Technology
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Institute of Liver and Biliary Sciences, India
Inuling (Bei Jing) Science and Technology Co. Ltd
Maharashtra Council of Indian Medicine
Memorial Hermann Health System
National Cerebral and Cardiovascular Center
Office of Dietary Supplements (ODS)
Pontificia Universidad Catolica de Chile
Singapore Clinical Research Institute
State University of New York, Buffalo
Steno Diabetes Center Copenhagen
Swiss Federal Institute of Technology
Taichung Veterans General Hospital
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
